D-0559-2016 Class II Terminated
FDA drug recall D-0559-2016 was initiated by PD-Rx Pharmaceuticals, Inc. on Jul 10, 2015 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Mar 8, 2017). Affected quantity: 9 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 6, 2016
- Initiation Date
- Jul 10, 2015
- Termination Date
- Mar 8, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9 bottles
Product description
Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottles, Rx only, Packaged by PD-RX Pharmaceuticals, Inc., Oklahoma City, OK 73127, MFG: Mutual Pharm. Co. Inc., Philadelphia, PA 19124, NDC 43063-509-01
Reason for recall
cGMP Deviations
Distribution pattern
Alabama
Code information
Lot# B14D26, Exp 02/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0559-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026